Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04893824 · ClinicalTrials.gov registry record
Grappler® Interference Screw Post-Market Clinical Follow-Up Study
A clinical trial, sponsored by Paragon 28.
- Completed
- Registry status
- 50
- Enrollment target
NCT04893824: Completed study, sponsored by Paragon 28.
NCT04893824 is a clinical trial that has completed, run by Paragon 28. The registered enrollment target is 50 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04893824 has completed, sponsored by Paragon 28.
- COMPLETED
- Registry status
- 50 participants
- Enrollment target
Study Summary
Ambispective, multi-surgeon, single site, consecutive case series to determine the safety, performance, and benefits of the Grappler(R) Interference Screw.
Primary Outcome
Safety will be assessed by recording the incidence of revisions. The relationship of events will be attributed to either the implant or instrumentation.
Interventions
- DEVICE Grappler® Interference Screw System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2021-04-19 |
| Est. Completion | 2022-03-25 |
What the finished NCT04893824 record still lists
NCT04893824 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 50 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Grappler® Interference Screw System is the first listed.
NCT04893824 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04893824 about?
NCT04893824 is a clinical study titled "Grappler® Interference Screw Post-Market Clinical Follow-Up Study". Ambispective, multi-surgeon, single site, consecutive case series to determine the safety, performance, and benefits of the Grappler(R) Interference Screw.
What is the current status of trial NCT04893824?
This trial is currently completed. The enrollment target is 50 participants. The study started on 2021-04-19. Estimated completion is 2022-03-25.
What interventions are being tested in trial NCT04893824?
The interventions under investigation include: Grappler® Interference Screw System (DEVICE).
Who is sponsoring clinical trial NCT04893824?
This trial is sponsored by Paragon 28, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI